TABLE 2.
Pooled proportion estimates of carbapenem resistance.
| Health status | Country | Pooled proportion (95% CI) | Heterogeneity (I2 in percentage) |
| Healthy | China | 0.88 (0–4.22) | 94.60* |
| Ghana | 100 (96.0–100) | NA | |
| Philippines | 3.64 (0.06–10.7) | NA | |
| Portugal | 0.13 (0–0.61) | 0 | |
| South Africa | 1.78 (0.22–4.45) | NA | |
| Tanzania | 4.95 (2.44–8.25) | NA | |
| Thailand | 1.37 (0–5.55) | 97.1* | |
| Vietnam | 2.6 (0.78–5.30) | 42.8 | |
| Countries with pooled proportions equal to zero | Rwanda, Uganda, Cambodia, Japan, Laos, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Grenada, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, North Macedonia, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom, Canada and United States of America | ||
| Diseased | China | 0.62 (0–3.04) | 56.3 |
| Europe | 0.14 (0.07–0.24) | NA | |
| India | 4.62 (0–23.8) | 92.0* | |
| South Korea | 1.09 (0–5.06) | 31 | |
| Thailand | 59.1 (51.7–66.3) | NA | |
| Countries with pooled proportions equal to zero | Australia: Austria and Switzerland: Japan and Taiwan | ||
*Heterogeneity was statistically significant (p < 0.05).
NA, estimates based on a single study and heterogeneity was not calculated.